Scientific publications for BioPredictive non-invasive diagnostics
Peer-reviewed studies validating BioPredictive blood-test diagnostics for liver disease — from first-in-class development cohorts to long-term meta-analyses.
20/433
Matches for
“STARD, Standards for the Reporting of Diagnostic Accuracy Studies”
-
FibroStic: a large confirmatory study for non-invasive biomarkers accuracy, if correctly interpreted.
-
Three Neglected STARD Criteria Reduce the Uncertainty of the Liver Fibrosis Biomarker FibroTest-T2D in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).
…An unmet need is to reduce the uncertainty of biomarkers for the…
-
Methodological aspects of the interpretation of non-invasive biomarkers of liver fibrosis: a 2008 update. Key publication
…As waiting for the perfect biomarker for the diagnosis of advanced fibrosis…
-
External validation of LCR1-LCR2, a multivariable HCC risk calculator, in patients with chronic HCV.
…the negative predictive value (NPV) of LCR1-LCR2 for the occurrence of…
-
Prognostic value of liver fibrosis biomarkers: a meta-analysis.
…4 (3 studies; 1,184 patients). For the prediction of survival without…
-
Noninvasive Markers of Hepatic Fibrosis in Chronic Hepatitis B.
…5 studies, 618 patients). For the diagnosis of advanced fibrosis, the standardized…
-
FibroTest-ActiTest as a non-invasive marker of liver fibrosis. Key publication
…the prognostic value of FT in CHC, CHB and ALD. For diagnostic…
-
Meta-analyses of FibroTest diagnostic value in chronic liver disease.
…The FT diagnostic value is similar for the diagnosis of intermediate and…
-
ActiTest accuracy for the assessment of histological activity grades in patients with chronic hepatitis C, an overview using Obuchowski measure.
…studies (2017 patients) were included. The overall accuracy of AT for the…
-
Assessment of liver fibrosis: noninvasive means.
…For FibroTest, the mean diagnostic value for the diagnosis of advanced fibrosis…
-
Impact of steatosis and inflammation definitions on the performance of NASH tests.
…We reviewed the landmark studies in metabolic liver disease, sources of the…
-
Biomarkers of liver fibrosis.
…The mean diagnostic value for the diagnosis of advanced fibrosis assessed using…
-
Noninvasive markers of fibrosis and inflammation in clinical practice: prospective comparison with liver biopsy.
### Background The efficiency of transient elastography for the assessment of liver fibrosis…
-
Improved diagnostic accuracy of blood tests for severe fibrosis and cirrhosis in chronic hepatitis C.
…We evaluated their diagnostic accuracy, and how to increase it, for the…
-
Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference.
…the validation of three blood tests used in NAFLD patients, FibroTest for…
-
Validation of AshTest as a Non-Invasive Alternative to Transjugular Liver Biopsy in Patients with Suspected Severe Acute Alcoholic Hepatitis.
…validate the AshTest accuracy in the specific context of use of patients…
-
Accuracy of the Enhanced Liver Fibrosis Test vs FibroTest, Elastography, and Indirect Markers in Detection of Advanced Fibrosis in Patients With Alcoholic Liver Disease.
…Secondary aims were to assess the diagnostic accuracy of ELF for significant…
-
Prospective external validation of a new non-invasive test for the diagnosis of non-alcoholic steatohepatitis in patients with type 2 diabetes.
…the ROC curve. ### Results The diagnostic performance of each component of the…
-
Diagnostic performance of a new noninvasive test for nonalcoholic steatohepatitis using a simplified histological reference.
…of this study was to construct a new quantitative test for the…
-
Systematic review with meta-analysis: direct comparisons of biomarkers for the diagnosis of fibrosis in chronic hepatitis C and B.
…we selected studies that directly compared the diagnostic accuracy of FibroTest, aspartate…
Showing the full result list. The page is server-rendered and not paginated.